SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

AEMD

Aethlon Medical Inc.
NASDAQHealth Care

Latest close: 5.15 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record89412 flagged findings
Reported transactions (Form 4)41since Feb 1, 2023
Corporate events (8-K)30since Nov 3, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 894)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 2 Form 4 filings newshow all 2hide
  • Oct 15, 26Form 4/A ↗Insider transaction · amendment new
  • Insider transaction · 3 Form 4 filings newshow all 3hide
  • Oct 13, 26SCHEDULE 13G ↗Passive stake · JANE STREET GROUP, LLC · 5.0% · event on Oct 6, 26 new
  • Oct 9, 268-K ↗Current report · Bylaws or fiscal year change
  • Oct 5, 268-K/A ↗Current report · Shareholder vote results · amendment
  • Oct 1, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 17, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 17, 268-K ↗Current report · Entered a material agreement
  • Sep 15, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 4, 26DEFA14A ↗Shareholder meeting and votes
  • Sep 1, 26DEF 14A ↗Shareholder meeting and votes
  • Aug 31, 268-K ↗Current report · Other events
  • Aug 21, 26PRE 14A ↗Shareholder meeting and votes
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K ↗Current report · Results · Communication to the market
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Mitchell P. Kopin · 2.3% · event on Jun 30, 26 · amendment
  • Jul 31, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change
  • Jul 8, 268-K ↗Current report · Entered a material agreement
  • Jul 7, 26424B3 ↗Securities offering
  • Insider transaction · 2 Form 4 filingsshow all 2hide

894 filings on record, the oldest from Mar 26, 99.

Listing the 25 most recent filings of the 894 on record.

8-Ks, explained

Stress8Structure114Governance48
  • Oct 1, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Sep 17, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Sep 15, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 8, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Feb 23, 26GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Jan 26, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Dec 8, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Oct 22, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 9, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Mar 17, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Jan 8, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 3, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗

15 older filings not shown · The record reaches back to May 23, 05.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Oct 27, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jul 11, 19StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 8, 19StressListing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
  • Aug 7, 17StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 7, 17StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • Feb 7, 17StressListing notice (8-K 3.01)8-K 3.01 ↗

The full record holds 8 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • JANE STREET GROUP, LLC5.0%Oct 6, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Armistice Capital, LLC5.0%Mar 31, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
  • Alumni Capital LP4.0%Oct 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Mitchell P. Kopin2.3%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Ikarian Capital, LLC2.0%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).

Stock compensation, tax and giftsshow the 40 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 8, 26Compensationamount n/aJAMES B FRAKESCFO/CEO↗
  • Oct 8, 26Compensationamount n/aSTEVEN P LAROSAChief Medical Officer↗
  • Sep 30, 26Tax$1KEDWARD G BROENNIMAN↗
  • Sep 30, 26Tax$3KNicolas Gikakis↗
  • Sep 30, 26Tax$3KChetan Shah↗
  • Jun 30, 26Tax$895EDWARD G BROENNIMAN↗
  • Jun 30, 26Tax$2KNicolas Gikakis↗
  • Jun 30, 26Tax$2KChetan Shah↗
  • Apr 17, 26Compensation$50KEDWARD G BROENNIMAN↗
  • Apr 17, 26Compensation$50KNicolas Gikakis↗
  • Apr 17, 26Compensation$50KChetan Shah↗
  • Apr 17, 26Compensation$50KAngela Rossetti↗
  • Mar 31, 26Tax$195EDWARD G BROENNIMAN↗
  • Mar 31, 26Tax$390Nicolas Gikakis↗
  • Mar 31, 26Tax$390Chetan Shah↗
  • Dec 31, 25Tax$247EDWARD G BROENNIMAN↗
  • Dec 31, 25Tax$496Nicolas Gikakis↗
  • Dec 31, 25Tax$496Chetan Shah↗
  • Sep 30, 25Tax$1KNicolas Gikakis↗
  • Sep 30, 25Tax$669EDWARD G BROENNIMAN↗
  • Sep 30, 25Tax$1KChetan Shah↗
  • Jun 30, 25Tax$2KChetan Shah↗
  • Jun 30, 25Tax$2KNicolas Gikakis↗
  • Jun 30, 25Tax$1KEDWARD G BROENNIMAN↗
  • Apr 23, 25Compensation$51KChetan Shah↗
  • Apr 23, 25Compensation$50KEDWARD G BROENNIMAN↗
  • Apr 23, 25Compensation$50KAngela Rossetti↗
  • Apr 23, 25Compensation$50KNicolas Gikakis↗
  • Mar 31, 25Tax$1KNicolas Gikakis↗
  • Mar 31, 25Tax$1KChetan Shah↗
  • Mar 31, 25Tax$589EDWARD G BROENNIMAN↗
  • Dec 31, 24Tax$3KNicolas Gikakis↗
  • Dec 31, 24Tax$3KChetan Shah↗
  • Dec 31, 24Tax$1KEDWARD G BROENNIMAN↗
  • Sep 30, 24Tax$2KChetan Shah↗
  • Sep 30, 24Tax$767EDWARD G BROENNIMAN↗
  • Sep 30, 24Tax$2KNicolas Gikakis↗
  • Jun 28, 24Tax$821EDWARD G BROENNIMAN↗
  • Jun 28, 24Tax$3KNicolas Gikakis↗
  • Jun 28, 24Tax$2KChetan Shah↗

The full record holds 61 transactions and goes back to Feb 1, 23.

Its sector and its market

Aethlon Medical Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Aethlon Medical Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Aethlon Medical Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
894 documents on file, from Mar 26, 1999 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 18, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.